SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-045127
Filing Date
2017-07-13
Accepted
2017-07-13 20:31:35
Documents
2
Period of Report
2017-07-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2743
2 POA DOCUMENT poa.txt EX-24.3_736629 3044
  Complete submission text file 0001209191-17-045127.txt   7154
Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Issuer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AKCEA THERAPAEUTICS 55 CAMBRIDGE PKWY, STE 100 CAMBRIDGE MA 02142
Business Address
Hochberg Elaine (Reporting) CIK: 0001703059 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38137 | Film No.: 17964378